Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025年3月12日 - 8:22AM
Edgar (US Regulatory)
Exhibit A
JOINT FILING AGREEMENT
The undersigned agree that
this Schedule 13G dated March 11, 2025 relating to the Common Stock, par value $0.0001 per share, of Aadi Bioscience, Inc. shall be filed
on behalf of the undersigned.
| |
SUVRETTA CAPITAL MANAGEMENT, LLC
By: /s/ Aaron Cowen |
| |
Name: Aaron Cowen |
| |
Title: Authorized Signatory |
| |
AVERILL MASTER FUND, LTD.
By: /s/ Aaron Cowen |
| |
Name: Aaron Cowen |
| |
Title: Director |
| |
AARON COWEN
By: /s/ Aaron Cowen |
Exhibit B
CONTROL PERSON IDENTIFICATION
Suvretta Capital Management, LLC is the relevant entity for which
Aaron Cowen is the control person.
Aadi Bioscience (NASDAQ:AADI)
過去 株価チャート
から 3 2025 まで 4 2025
Aadi Bioscience (NASDAQ:AADI)
過去 株価チャート
から 4 2024 まで 4 2025
